Coagulation Analyzers in India: 7 Costly Mistakes Labs Are Still Making
Introduction: Choosing the Right Coagulation Analyzer is No Longer Optional
In India, with increasing demand for PT, aPTT, Fibrinogen & D-Dimer tests, many labs are investing in coagulation analyzers. But surprisingly, most small and mid-size labs still repeat 7 critical mistakes while choosing or using these analyzers — leading to higher costs, errors, and poor patient reporting.
Mistake #1: Still Investing in BT/CT Based Testing
- BT/CT are outdated & unreliable. Avoid them
- Choose to perform the PT & aPTT instead as they more significant and are globally accepted tests
- Choose the right brand and solutions from the right vendor
TIP: Semi-automated coagulation analysers like FibriTimer Zeta-1
Mistake #2: Choosing Analysers with Closed Reagent Systems
- Increases long-term operational cost
- Limited flexibility
- Dependency on one brand
Best Practice: Opt for Open System Analyzers (like Operon’s range) supporting validated, affordable multi reagent brands.
Mistake #3: Ignoring Dual Technology Advantage
Many labs regret buying analyzers without dual clot detection (Mechanical + Optical).
- Poor performance in turbid or lipemic samples
- Cannot handle complex testing scenarios
Solution: FibriTimer Zeta-1 with patented Dual Technology ensures accurate reporting even with difficult samples.
Mistake #4: Overlooking Built-in Power Backup
- Frequent power cuts in Tier 2, 3 cities disrupt reporting
- Risk of incomplete tests
Advantage: FibriTimer Zeta-1 comes with 4-5 hours in-built UPS backup for uninterrupted operations.
Mistake #5: Going for Fully Automated Systems without Volume Justification
- High cost of ownership
- Reagent wastage
- Not suitable for labs with <25 samples/day
Smart Move: Start with semi-automated analyzers like Zeta Series. Upgrade later if required.
Mistake #6: Neglecting Technical Support & Training
- Coagulation testing needs expertise
- Improper calibration = Reporting errors
Why Operon Stands Out: Pan-India service support, training from coagulation experts, and lab QC guidance.
Mistake #7: Not Considering Made-in-India Solutions
- Indian labs need affordable & suitable analyzers
- Imported devices = higher maintenance cost
Operon Biotech Advantage: Indigenous design, affordable pricing, and customized features for Indian labs.
Final Thoughts
Buying a coagulation analyzer is a long-term investment. Avoid these 7 mistakes and choose wisely.
Explore Operon’s trusted solutions:
- FibriTimer Zeta-1 & Zeta-2 (Semi-automated)
- XL-1000 Series (Entry-level automation)
- XL-3600 (High-end automation)
Visit: www.operonbiotech.com
